The stock market’s tumultuous start to 2026 has been notable, with larger indices like the S&P 500 experiencing a decline of 0.5%, primarily driven by a significant sell-off in software stocks. In contrast, small-cap stocks have shown resilience, with the Russell 2000 index gaining 4% during the same period. While this outperformance may tempt some investors to dive headfirst into small-cap stocks, caution is advised due to the unique risks associated with these companies.
Small-cap stocks are notoriously sensitive to economic fluctuations and interest rate changes. Their lack of diversification and tendency to rely on borrowing mean that rising interest rates can dramatically increase their financing costs. Additionally, these companies often have high dividend payout ratios, which could put pressure on them to cut or suspend dividend payments during economic downturns.
Investors typically gravitate toward larger, established companies like Coca-Cola, McDonald’s, and IBM for reliable dividend payments. However, for those willing to embrace the risks for potential rewards, certain small-cap stocks may present attractive opportunities for income generation coupled with the prospect of capital appreciation.
A recent CNBC screening highlighted several small-cap stocks within the Russell 2000 that boast market capitalizations above $1 billion, receive strong buy recommendations from analysts, and offer dividends. Among these, Spectrum Brands stood out, known for its products like Cutter insect repellent and Nature’s Miracle pet supplies. The company’s shares surged 27% in 2026, and it currently offers a dividend yield of 2.5%. In its recent fiscal first quarter results, Spectrum exceeded Wall Street expectations for both revenue and earnings. CEO David Maura expressed satisfaction with the positive performance, particularly noting growth in their Global Pet Care segment.
Concentra Group, a provider of occupational health services, is another small-cap stock that has made notable gains, with shares increasing nearly 20% this year and a dividend yield of about 1.1%. The company recently released preliminary fourth-quarter figures revealing adjusted earnings of 28 cents per share against revenue of $539.1 million, outperforming analysts’ expectations. Mizuho analyst Ann Hynes praised the company’s results and highlighted its strong positioning and acquisition strategy as compelling factors for long-term investment.
Concentra has renewed focus on acquiring occupational health practices, recently announcing the acquisition of Reliant Immediate Care’s assets in California, which includes multiple locations in Los Angeles.
Other notable stocks emerging from the screening include WD-40, Upbound Group, Select Water Solutions, and U.S. Physical Therapy, each presenting unique opportunities in the small-cap segment as investors navigate the current market landscape.
